Skip to main content

Immuno Oncology Assays Market Competitive Landscape and Application Development Analysis to 2027

Press release   •   Sep 17, 2019 12:34 IST

The immuno oncology assays market is expected to grow exponentially in the forecast period owing to the factors such as increasing number of cancer prevalence, patient preference towards immunotherapies and immunodiagnostics due to side effects of radiation and chemotherapy and technological advances in the immuno oncology assays. Furthermore, high potential growth from emerging nations is anticipated to offer significant growth opportunities in the market during the forecast period.

Immuno oncology assays includes the use of various immunology assays that are used to monitor the interaction between immune cells and cancer cells. The immune system of human body has a great potential to destroy tumor cells producing no toxicity to normal cells. Moreover, the immune system also has an ability to prevent recurrence of cancer.

Get PDF sample copy: https://www.theinsightpartners.com/sample/TIPRE00006575/

The global immuno oncology assays market is segmented on the basis of technology, Indication, and application. Based on technology, the market is classified as immunoassays, PCR, NGS, flow cytometry, and others. Based on indication, the market is classified as colorectal cancer, lung cancer, melanoma, bladder cancer, and others. On the basis of application the immuno oncology assays market is classified as clinical diagnostics, and research.

Leading Players:

1. Agilent Technologies, Inc.
2. F. Hoffmann-La Roche Ltd
3. HTG Molecular Diagnostics, Inc.
4. Illumina, Inc.
5. Merck KGaA
6. PerkinElmer Inc.
7. Thermo Fisher Scientific Inc.
8. Qiagen
9. Sartorius AG

10. NanoString Technologies, Inc. 

The report analyzes factors affecting immuno oncology assays market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the immuno oncology assays market in these regions.

Buy the complete report with Comprehensive table of contents @ https://www.theinsightpartners.com/buy/TIPRE00006575/

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global immuno oncology assays market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The immuno oncology assays market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, Healthcare and Telecommunication industries.

Comments (0)

Add comment

Comment

By submitting the comment you agree that your personal data will be processed according to Mynewsdesk's Privacy Policy.